ArticleDiscover oncology2026
Cervical cancer derived extracellular vesicles expressed higher level of CD24 and suppressed the phagocytosis of macrophages.
Article in Discover oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCervical cancer represents one of the most common malignant tumors affecting women worldwide with unsatisfactory therapeutic outcome. CD24 is well acknowledged that could express on cancer cell and block the phagocytosis of macrophages in tumor microenvironment. However, it is unclear whether the cervical cancer derived extracellular vesicles (CC-EVs) block the phagocytosis of macrophages.
methodsCD24 expression was detected in cervical cancer tissues. The CC-EVs were isolated to treat the macrophages. Furthermore, the CD24 expression was detected in CC-EVs. Then we isolated CD24-EVs through transient transfection and CD24
resultsCervical cancer derived EVs could decrease the phagocytosis of macrophages. The CC-EVs expressed high level of CD24, which play the key role in blocking the phagocytosis of macrophages.
conclusionsThe cervical cancer derived EVs express higher level of CD24, which inhibits the phagocytosis of macrophages.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.